Concepedia

Jamie B. Miyamoto

JB

Statistics

Publications

20

Citations

2.1K

H-Index

17

Active since

2007

Affiliations

Seagen (United States)(Current)

Jamie B. Miyamoto is an author at Seagen (United States) specializing in medicine, immunology, and pharmacology.

Top concepts

Publications per year

2007–2020

20

Publications

20

Intracellular Activation of SGN-35, a Potent Anti-CD30 Antibody-Drug Conjugate

Nicole M. Okeley, Jamie B. Miyamoto, Xinqun Zhang et al. · Clinical Cancer Research · 2010 · 381 citations · Full text

Intracellular Released Payload Influences Potency and Bystander-Killing Effects of Antibody-Drug Conjugates in Preclinical Models

Li Fu, Kim K. Emmerton, Mechthild Jonas et al. · Cancer Research · 2016 · 302 citations

, , +16

A Potent Anti-CD70 Antibody–Drug Conjugate Combining a Dimeric Pyrrolobenzodiazepine Drug with Site-Specific Conjugation Technology

Scott C. Jeffrey, Patrick Burke, Robert P. Lyon et al. · Bioconjugate Chemistry · 2013 · 241 citations

, , +21

Novel Peptide Linkers for Highly Potent Antibody−Auristatin Conjugate

Svetlana O. Doronina, Tim D. Bovee, David W. Meyer et al. · Bioconjugate Chemistry · 2008 · 171 citations

, , +17

Optimization of a PEGylated Glucuronide-Monomethylauristatin E Linker for Antibody–Drug Conjugates

Patrick Burke, Joseph Z. Hamilton, Scott C. Jeffrey et al. · Molecular Cancer Therapeutics · 2016 · 142 citations

1–5 of 20